Tn‐C is, for example, further described to disturb the blood‐brain barrier in an experimental mouse model and it is also upregulated and detectable in MS sera and lesions (Gutowski et al., 1999; Harada et al., 2015). Here, TNC is linked to myeloid sarcoma.